Blackford Analysis

Blackford Analysis, now part of Bayer, is an Enterprise AI partner in the healthcare sector, focusing on radiology AI imaging. Founded in 2009 as a University of Edinburgh spinout, the company offers a unified platform that simplifies the integration and management of AI applications for medical imaging. The Blackford Platform features a curated marketplace with over 135 regulatory-approved AI algorithms, ensuring users have access to diverse tools for enhanced clinical practices.

The platform is fully DICOM-compliant and integrates with HL7, connecting seamlessly with existing healthcare infrastructures. It includes real-time performance monitoring to maintain operational efficiency. Blackford specializes in radiology imaging, aiming to accelerate workflows, reduce care costs, and improve diagnostic confidence. The company serves a wide range of clinical institutions, healthcare professionals, and research groups, providing tailored solutions to enhance patient outcomes and drive efficiencies in the healthcare system.